ARCHIVES

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

This article is from The Cancer Letter archive.

Vol. 04 No. 44 | November 3, 1978

Download PDF Visit The Full Archive

Related Articles

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

In Brief: Gifts to NCI Totaled $332,226 In Fiscal 1986; Position Freeze Said To Hurt DCE Labs

January 3, 1986

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008